Literature DB >> 15814974

Rapid detection of ofloxacin resistance in Mycobacterium tuberculosis by two low-cost colorimetric methods: resazurin and nitrate reductase assays.

Anandi Martin1, Juan Carlos Palomino, Françoise Portaels.   

Abstract

We have evaluated the performance of two rapid, low-cost methods for the detection of ofloxacin (OFX) resistance with 95 Mycobacterium tuberculosis isolates from countries with high multidrug-resistant tuberculosis endemicity. Results obtained by nitrate reductase and resazurin assays showed 100% agreement with those of the proportion method on 7H11 agar using 2 mug of OFX/ml. We confirmed the resistance of all isolates found to be resistant to OFX by the Mycobacterium Growth Indicator Tube system, and complete agreement among all methods was observed. Nitrate reductase and resazurin assays are rapid, simple, low-cost methods and might become inexpensive alternative procedures for rapid detection of OFX resistance in low-resource countries.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15814974      PMCID： PMC1081354          DOI： 10.1128/JCM.43.4.1612-1616.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  35 in total

Review 1.  Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?

Authors:  R Gupta; M C Raviglione; M A Espinal
Journal:  Int J Tuberc Lung Dis       Date:  2001-12       Impact factor: 2.373

2.  Kanamycin susceptibility testing of Mycobacterium tuberculosis using Mycobacterium Growth Indicator Tube and a colorimetric method.

Authors:  I Bastian; L Rigouts; J C Palomino; F Portaels
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

Authors:  M A Espinal; A Laszlo; L Simonsen; F Boulahbal; S J Kim; A Reniero; S Hoffner; H L Rieder; N Binkin; C Dye; R Williams; M C Raviglione
Journal:  N Engl J Med       Date:  2001-04-26       Impact factor: 91.245

Review 4.  Fluoroquinolones and tuberculosis.

Authors:  André Bryskier; John Lowther
Journal:  Expert Opin Investig Drugs       Date:  2002-02       Impact factor: 6.206

5.  Rapid and inexpensive drug susceptibility testing of Mycobacterium tuberculosis with a nitrate reductase assay.

Authors:  K A Kristian Angeby; Lisbeth Klintz; Sven E Hoffner
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

6.  Increased resistance to ciprofloxacin and ofloxacin in multidrug-resistant mycobacterium tuberculosis isolates from patients seen at a tertiary hospital in the Philippines.

Authors:  E R Grimaldo; T E Tupasi; A B Rivera; M I Quelapio; R C Cardaño; J O Derilo; V A Belen
Journal:  Int J Tuberc Lung Dis       Date:  2001-06       Impact factor: 2.373

7.  Molecular characterization of multidrug-resistant isolates of Mycobacterium tuberculosis from patients in North India.

Authors:  Noman Siddiqi; Mohammed Shamim; Seema Hussain; Rakesh Kumar Choudhary; Niyaz Ahmed; Sharmistha Banerjee; G R Savithri; Mahfooz Alam; Niteen Pathak; Amol Amin; Mohammed Hanief; V M Katoch; S K Sharma; Seyed E Hasnain
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

Review 8.  The role of fluoroquinolones in tuberculosis today.

Authors:  S E Berning
Journal:  Drugs       Date:  2001       Impact factor: 9.546

9.  Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries.

Authors:  M A Espinal; S J Kim; P G Suarez; K M Kam; A G Khomenko; G B Migliori; J Baéz; A Kochi; C Dye; M C Raviglione
Journal:  JAMA       Date:  2000-05-17       Impact factor: 56.272

10.  Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis.

Authors:  Juan-Carlos Palomino; Anandi Martin; Mirtha Camacho; Humberto Guerra; Jean Swings; Françoise Portaels
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191
View more
  10 in total

1.  Evaluation of direct detection of Mycobacterium tuberculosis rifampin resistance by a nitrate reductase assay applied to sputum samples in Cotonou, Benin.

Authors:  Dissou Affolabi; Mathieu Odoun; Anandi Martin; Juan Carlos Palomino; Séverin Anagonou; Françoise Portaels
Journal:  J Clin Microbiol       Date:  2007-05-02       Impact factor: 5.948

2.  Fluoroquinolone resistance in Mycobacterium tuberculosis: an assessment of MGIT 960, MODS and nitrate reductase assay and fluoroquinolone cross-resistance.

Authors:  Rose A Devasia; Amondrea Blackman; Carolyn May; Svetlana Eden; Teresa Smith; Nancy Hooper; Fernanda Maruri; Charles Stratton; Ayumi Shintani; Timothy R Sterling
Journal:  J Antimicrob Chemother       Date:  2009-03-28       Impact factor: 5.790

3.  Rapid detection of Mycobacterium tuberculosis resistance to second-line drugs by use of the manual mycobacterium growth indicator tube system.

Authors:  Anandi Martin; Andrea von Groll; Krista Fissette; Juan Carlos Palomino; Francis Varaine; Françoise Portaels
Journal:  J Clin Microbiol       Date:  2008-10-22       Impact factor: 5.948

4.  Fluoroquinolone resistance in Mycobacterium tuberculosis and mutations in gyrA and gyrB.

Authors:  Andrea Von Groll; Anandi Martin; Pontus Jureen; Sven Hoffner; Peter Vandamme; Françoise Portaels; Juan Carlos Palomino; Pedro Almeida da Silva
Journal:  Antimicrob Agents Chemother       Date:  2009-08-17       Impact factor: 5.191

5.  Evaluation of the performance of nitrate reductase assay for rapid drug-susceptibility testing of mycobacterium tuberculosis in north India.

Authors:  Anamika Gupta; Malay Ranjan Sen; Tribhuban Mohan Mohapatra; Shampa Anupurba
Journal:  J Health Popul Nutr       Date:  2011-02       Impact factor: 2.000

6.  Complex Formation of Resorufin and Resazurin with Β-Cyclodextrins: Can Cyclodextrins Interfere with a Resazurin Cell Viability Assay?

Authors:  Rita Csepregi; Beáta Lemli; Sándor Kunsági-Máté; Lajos Szente; Tamás Kőszegi; Balázs Németi; Miklós Poór
Journal:  Molecules       Date:  2018-02-10       Impact factor: 4.411

7.  Bedaquiline Drug Resistance Emergence Assessment in Multidrug-Resistant Tuberculosis (MDR-TB): a 5-Year Prospective In Vitro Surveillance Study of Bedaquiline and Other Second-Line Drug Susceptibility Testing in MDR-TB Isolates.

Authors:  Koné Kaniga; Rumina Hasan; Ruwen Jou; Edita Vasiliauskienė; Charoen Chuchottaworn; Nazir Ismail; Beverly Metchock; Skaidrius Miliauskas; Nguyen Viet Nhung; Camilla Rodrigues; Soyoun Shin; Hulya Simsek; Saijai Smithtikarn; Anh Le Thi Ngoc; Jirakan Boonyasopun; Mubin Kazi; Seungmo Kim; Phalin Kamolwat; Greta Musteikiene; Catherine Ann Sacopon; Sabira Tahseen; Laima Vasiliauskaitė; Mei-Hua Wu; Shaheed Vally Omar
Journal:  J Clin Microbiol       Date:  2021-10-27       Impact factor: 11.677

8.  Molecular Epidemiology and Polymorphism Analysis in Drug-Resistant Genes in M. tuberculosis Clinical Isolates from Western and Northern India.

Authors:  Vibhuti Rana; Nittu Singh; Chaitali Nikam; Priti Kambli; Pravin K Singh; Urmila Singh; Amita Jain; Camilla Rodrigues; Charu Sharma
Journal:  Infect Drug Resist       Date:  2022-04-08       Impact factor: 4.003

9.  Evaluation of MGIT 960 System for the Second-Line Drugs Susceptibility Testing of Mycobacterium tuberculosis.

Authors:  Hyejin Kim; Minji Seo; Young Kil Park; Jae-Il Yoo; Yeong Seon Lee; Gyung Tae Chung; Sungweon Ryoo
Journal:  Tuberc Res Treat       Date:  2013-03-28

10.  Comparative evaluation of the Nitrate Reductase Assay and the Resazurin Microtitre Assay for drug susceptibility testing of Mycobacterium tuberculosis against first line anti-tuberculosis drugs.

Authors:  Karine O Sanchotene; Andrea von Groll; Daniela Ramos; Ana B Scholante; Gunther Honscha; Mariana Valença; Carlos J Scaini; Pedro E A da Silva
Journal:  Braz J Microbiol       Date:  2008-03-01       Impact factor: 2.476
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.